AI-generated from publicly available materials.In an insightful discussion, Mark Beers from Swisslog highlighted the pivotal role software plays in evolving pharmaceutical supply chains to meet new demands.
As pharmaceutical companies increasingly focus on biologics and specialty medicines, many existing warehouses and automation systems are ill-equipped to handle these changes. Beers emphasizes that software serves as a crucial link between outdated infrastructure and the dynamic needs of modern product and regulatory landscapes. This adaptability is essential for maintaining efficiency and compliance in a rapidly shifting market.
During the LogiPharma USA 2026 conference, Beers moderated a session focused on enhancing quality and compliance within a volatile global supply chain. Key discussions revolved around the importance of supplier qualification and harmonizing compliance measures, underscoring that connected data and risk-based prioritization should take precedence over AI in ensuring supply chain integrity.
Industry leaders from companies such as J&J and Sun Pharma also addressed the complexities of visibility and redundancy in supply chains, indicating that a strategic approach, bolstered by software solutions, is vital for resilience in the pharmaceutical sector. As the landscape continues to evolve, companies must prioritize technological integration to sustain their operations and build trust with stakeholders.